Meeder Asset Management Inc Rvl Pharmaceuticals PLC Transaction History

Meeder Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$4.12 - $6.29 $46,209 - $70,548	-11,216 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.18 - $7.0 $11,438 - $25,179	3,597 Added 47.21%	11,216 $35,000
Q4 2019 Feb 13, 2020	BUY	$3.46 - $7.7 $6,276 - $13,967	1,814 Added 31.25%	7,619 $54,000
Q3 2019 Oct 17, 2019	BUY	$2.8 - $3.99 $11,208 - $15,971	4,003 Added 222.14%	5,805 $22,000
Q2 2019 Aug 05, 2019	BUY	$2.34 - $4.28 $4,216 - $7,712	1,802 New	1,802 $7,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.